- Home
- FLGT vs CANG Comparison
FLGT vs CANG Comparison
Compare FLGT & CANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- CANG
- Stock Information
- Founded
- FLGT 2011
- CANG 2010
- Country
- FLGT United States
- CANG China
- Employees
- FLGT N/A
- CANG N/A
- Industry
- FLGT Medical Specialities
- CANG Computer Software: Prepackaged Software
- Sector
- FLGT Health Care
- CANG Technology
- Exchange
- FLGT Nasdaq
- CANG Nasdaq
- Market Cap
- FLGT 587.3M
- CANG 544.1M
- IPO Year
- FLGT 2016
- CANG 2018
- Fundamental
- Price
- FLGT $18.07
- CANG $5.04
- Analyst Decision
- FLGT Buy
- CANG
- Analyst Count
- FLGT 2
- CANG 0
- Target Price
- FLGT $24.00
- CANG N/A
- AVG Volume (30 Days)
- FLGT 210.6K
- CANG 676.8K
- Earning Date
- FLGT 08-01-2025
- CANG 08-28-2025
- Dividend Yield
- FLGT N/A
- CANG N/A
- EPS Growth
- FLGT N/A
- CANG N/A
- EPS
- FLGT N/A
- CANG 0.00
- Revenue
- FLGT $292,448,000.00
- CANG $247,219,627.00
- Revenue This Year
- FLGT $11.79
- CANG $431.64
- Revenue Next Year
- FLGT $10.45
- CANG $23.36
- P/E Ratio
- FLGT N/A
- CANG $2,721.71
- Revenue Growth
- FLGT 1.71
- CANG 46.60
- 52 Week Low
- FLGT $14.57
- CANG $1.40
- 52 Week High
- FLGT $25.11
- CANG $9.66
- Technical
- Relative Strength Index (RSI)
- FLGT 29.01
- CANG 53.28
- Support Level
- FLGT $19.18
- CANG $5.12
- Resistance Level
- FLGT $19.96
- CANG $5.75
- Average True Range (ATR)
- FLGT 0.56
- CANG 0.34
- MACD
- FLGT -0.15
- CANG 0.03
- Stochastic Oscillator
- FLGT 0.86
- CANG 52.01
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About CANG Cango Inc. each representing two (2)
Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and related businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives majority of its revenue from the bitcoin mining business.